ClinConnect ClinConnect Logo
Search / Trial NCT04349774

Erector Spinae Plane Block vs Erector Spinae Plane Block With Serratus Anterior Plane Block in Thoracic Surgery

Launched by ANNA USKOVA · Apr 15, 2020

Trial Information

Current as of May 19, 2025

Withdrawn

Keywords

Erector Spinae Plane Block Serratus Anterior Plane Block Thoracic Surgery Post Operative Pain

ClinConnect Summary

Once consented, the patient will be randomized by computer generated random number to one of the two treatment groups.

Blinding Plan: At the acute pain management office, one member of the research team will be responsible for providing the anesthesiologist in charge of performing the block with a sealed envelope. Each envelope will be labeled with a number corresponding to a matching number labeled on each patient binder. This envelope will contain the randomized block to be administered - ESP with SAP or ESP with SAP normal saline. Once the anesthesiologist knows which block combination ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients 18-80 years old
  • Primary Unilateral Thoracic Surgery
  • BMI 20 - 36, weight \> or = to 50kg
  • Male and Female
  • All races
  • Exclusion Criteria:
  • Patient refusal
  • Inpatient status at time of surgery
  • ASA class \> or = 4
  • Bilateral thoracic surgery
  • Pregnancy
  • Non-English speaking or inability to participate in the study
  • Patients with coagulopathy or on therapeutic anticoagulation
  • Chronic Steroid Use
  • Narcotic Addiction
  • Patients with contraindication to performing either block - active infection at block site, systemic infection, allergy to local anesthetic medications
  • Patients undergoing second surgery or urgent/emergent surgery
  • Patients weighing \<50kg

About Anna Uskova

Anna Uskova is a dedicated clinical trial sponsor focused on advancing medical research through innovative and rigorous study designs. With a commitment to enhancing patient outcomes, the organization collaborates closely with healthcare professionals, regulatory bodies, and research institutions to develop and implement clinical trials that adhere to the highest ethical and scientific standards. Driven by a passion for improving health solutions, Anna Uskova aims to accelerate the development of new therapies and contribute to the advancement of medical knowledge across various therapeutic areas.

Locations

Pittsburgh, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Dmitriy Gromov, DO

Principal Investigator

University of Pittsburgh Medical Center

Anna Uskova, MD

Study Director

University of Pittsburgh Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials